IR@PKUHSC  > 北京大学基础医学院  > 病理学系
学科主题基础医学
Tumor-specific methylation of the 8p22 tumor suppressor gene DLC1 is an epigenetic biomarker for Hodgkin, nasal NK/T-cell and other types of lymphomas
Ying, Jianming2,3; Li, Hongyu2,3; Murray, Paul4; Gao, Zifen5; Chen, Yun-Wen1; Wang, Yajun2,3; Lee, Kwan Yeung2,3; Chan, Anthony T. C.2,3; Ambinder, Richard F.; Srivastava, Gopesh1; Tao, Qian2,3,6
关键词DLC1 methylation biomarker lymphoma tumor suppressor gene
刊名EPIGENETICS
2007
2期:1页:15-21
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Biochemistry & Molecular Biology
研究领域[WOS]Biochemistry & Molecular Biology
关键词[WOS]EPSTEIN-BARR-VIRUS ; ABERRANT DNA METHYLATION ; STRESS-RESPONSIVE GENE ; HUMAN BREAST-CANCER ; PROMOTER HYPERMETHYLATION ; HEMATOPOIETIC MALIGNANCIES ; HEPATOCELLULAR-CARCINOMA ; NASOPHARYNGEAL CARCINOMA ; FUNDAMENTAL ROLE ; SERUM DNA
英文摘要

Aberrant promoter methylation is an epigenetic mechanism for silencing tumor suppressor genes (TSG), and is also a biomarker for early cancer diagnosis and prognosis prediction. Recently, we and others identified DLC1 (ARHGAP7) as a functional TSG frequently methylated in multiple carcinomas. Here, we further uncovered DLC1 as one of the up-regulated genes in lymphoma cell lines after pharmacologic demethylation with 5-aza-2 ′-deoxycytidine (Aza). Transcriptional silencing and methylation of DLC1 was detected in most Hodgkin (HL) and non-Hodgkin lymphoma (NHL) cell lines, including 4/6 Hodgkin, 4/4 nasal NK/T-cell, 6/6 Burkitt and 5/5 diffuse large B-cell lymphoma cell lines. Aza treatment led to DLC1 promoter demethylation and transcriptional reactivation in silenced cell lines, indicating a methylation-mediated silencing. Aberrant methylation was further detected in 44% (14/37) Hodgkin, 77% (34/44) nasal NK/T-cell and 60-90% of various types of primary NHLs, but not in any normal lymph node or PBMC sample, and is thus tumor-specific. Analysis of microdissected Hodgkin/Reed-Sternberg (HRS) cells from HL cases confirmed the site of methylation as tumor cells. Moreover, DLC1 methylation was detected in 4/14 (29%) serum samples from HL patients. Our results indicate that DLC1 methylation is a frequent event in multiple lymphomagenesis and could serve as a tumor-specific biomarker for future lymphoma diagnosis.

语种英语
WOS记录号WOS:000256223000005
引用统计
被引频次:20[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
版本出版稿
条目标识符http://ir.bjmu.edu.cn/handle/400002259/67810
专题北京大学基础医学院_病理学系
北京大学基础医学院
作者单位1.Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China
2.Chinese Univ Hong Kong, Hong Kong Canc Inst, Dept Clin Oncol,Canc Epigenet Lab, Sir YK Pao Ctr Canc,State Key Lab Oncol S China, Hong Kong, Hong Kong, Peoples R China
3.Chinese Univ Hong Kong, Li Ka Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China
4.Univ Birmingham, Canc Res UK Inst Canc Studies, Birmingham, W Midlands, England
5.Peking Univ, Hlth Sci Ctr, Dept Pathol, Beijing 100871, Peoples R China
6.Johns Hopkins Sch Med, Johns Hopkins Singapore & Sidney Kimmel Comprehen, Baltimore, MD USA
推荐引用方式
GB/T 7714
Ying, Jianming,Li, Hongyu,Murray, Paul,et al. Tumor-specific methylation of the 8p22 tumor suppressor gene DLC1 is an epigenetic biomarker for Hodgkin, nasal NK/T-cell and other types of lymphomas[J]. EPIGENETICS,2007,2(1):15-21.
APA Ying, Jianming.,Li, Hongyu.,Murray, Paul.,Gao, Zifen.,Chen, Yun-Wen.,...&Tao, Qian.(2007).Tumor-specific methylation of the 8p22 tumor suppressor gene DLC1 is an epigenetic biomarker for Hodgkin, nasal NK/T-cell and other types of lymphomas.EPIGENETICS,2(1),15-21.
MLA Ying, Jianming,et al."Tumor-specific methylation of the 8p22 tumor suppressor gene DLC1 is an epigenetic biomarker for Hodgkin, nasal NK/T-cell and other types of lymphomas".EPIGENETICS 2.1(2007):15-21.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
Tumor-specific methy(3032KB)期刊论文出版稿开放获取CC BY-NC-SA浏览 请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Ying, Jianming]的文章
[Li, Hongyu]的文章
[Murray, Paul]的文章
百度学术
百度学术中相似的文章
[Ying, Jianming]的文章
[Li, Hongyu]的文章
[Murray, Paul]的文章
必应学术
必应学术中相似的文章
[Ying, Jianming]的文章
[Li, Hongyu]的文章
[Murray, Paul]的文章
相关权益政策
暂无数据
收藏/分享
文件名: Tumor-specific methylation of the 8p22 tumor suppressor gene DLC1 is an epigenetic biomarker for Hodgkin, nasal NK T-cell and other types of lymphomas.pdf
格式: Adobe PDF
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。